Premium
Biocatalytic Synthesis of the Anti‐diabetes Agent‐corosolic Acid by Whole Cells of Microorganisms
Author(s) -
Fu Shaobin,
Meng Qingfeng,
Long Shuan,
Zhang Yun,
Sun Dian,
Wei Gang
Publication year - 2015
Publication title -
journal of the chinese chemical society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.329
H-Index - 45
eISSN - 2192-6549
pISSN - 0009-4536
DOI - 10.1002/jccs.201500035
Subject(s) - chemistry , streptomyces griseus , ursolic acid , natural product , biochemistry , combinatorial chemistry , streptomyces , bacteria , chromatography , biology , genetics
Diabetes is one of the most prevalent and costly global diseases. For diabetes, frequent insulin treatment and synthetic drugs are very expensive and may cause unwanted side effects. Corosolic acid (CA), a natural product, was reported to be efficient in the treatment of diabetes, meanwhile without induction of anti‐insulin antibodies and obesity. The preparation of CA attracted many researchers in the world. This study investigated the biocatalytic synthesis method of CA from ursolic acid by Streptomyces griseus subsp. griseus 4.18. LCMS analysis demonstrated that 5 day, 125 μg/mL substrate, pH=9 and 10% strain concentration were the appropriate conditions. It is estimated that biocatalysis will contribute to the development of green and sustainable synthetic processes with less time‐consuming and more environmentally friendly.